PT Carsurin Tbk (IDX:CRSN)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
107.00
-4.00 (-3.60%)
Aug 1, 2025, 4:06 PM WIB

CTI BioPharma Revenue

PT Carsurin Tbk had revenue of 117.13B IDR in the quarter ending June 30, 2025, with 22.44% growth. This brings the company's revenue in the last twelve months to 493.53B, up 14.60% year-over-year. In the year 2024, PT Carsurin Tbk had annual revenue of 448.51B with 0.92% growth.

Revenue (ttm)
493.53B
Revenue Growth
+14.60%
P/S Ratio
0.63
Revenue / Employee
489.13M
Employees
1,001
Market Cap
309.44B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024448.51B4.09B0.92%
Dec 31, 2023444.43B81.06B22.31%
Dec 31, 2022363.37B44.78B14.05%
Dec 31, 2021318.59B39.75B14.26%
Dec 31, 2020278.84B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition